Palisade Bio (PALI) Change in Cash (2010 - 2026)
Palisade Bio (PALI) reported Change in Cash of -$757000.0 for Q1 2026, up 70.78% year-over-year from -$443251.3 in Q1 2025, and down 100.59% quarter-over-quarter from $128.2 million in Q4 2025.
Palisade Bio (PALI) Change in Cash (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has 17 years of Change in Cash data on file, last reported at -$757000.0 in Q1 2026.
- Change in Cash for Q1 2026 came in at -$757000.0, up 70.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $125.4 million (up 3200.02% YoY), and the FY2025 annual result was $123.6 million, up 4833.55% from the prior year.
- Change in Cash slipped to -$757000.0 in Q1 2026 per PALI's latest filing, from $128.2 million in the prior quarter.
- Over five years, Change in Cash peaked at $128.2 million in Q4 2025 and troughed at -$3.9 million in Q1 2022.
- A 5-year average of $7.2 million and a median of -$1.1 million in 2023 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2022 and 2025: Change in Cash slumped 3829.59% in 2022, then soared 7097.47% in 2025.
- A 5-year view of Change in Cash shows it stood at -$1.6 million in 2022, then slumped by 79.78% to -$2.9 million in 2023, then jumped by 161.84% to $1.8 million in 2024, then soared by 7097.47% to $128.2 million in 2025, then plunged by 100.59% to -$757000.0 in 2026.
- Business Quant data shows PALI's Change in Cash at -$757000.0 in Q1 2026, $128.2 million in Q4 2025, and -$190000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - | -757,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -757,000.00 |
| Dec 31, 2025 | 128.19 Mn |
| Sep 30, 2025 | -190,000.00 |
| Jun 30, 2025 | -1.81 Mn |
| Mar 31, 2025 | -2.59 Mn |
| Dec 31, 2024 | 1.78 Mn |
| Sep 30, 2024 | -3.31 Mn |
| Jun 30, 2024 | 77,000.00 |
| Mar 31, 2024 | -1.16 Mn |
| Dec 31, 2023 | -2.88 Mn |
| Sep 30, 2023 | -1.09 Mn |
| Jun 30, 2023 | 3.11 Mn |
| Mar 31, 2023 | 914,000.00 |
| Dec 31, 2022 | -1.60 Mn |
| Sep 30, 2022 | 9.01 Mn |
| Jun 30, 2022 | -1.66 Mn |
| Mar 31, 2022 | -3.85 Mn |
| Dec 31, 2021 | -3.61 Mn |
| Sep 30, 2021 | 1.45 Mn |
| Jun 30, 2021 | 12.04 Mn |